Code | CSB-YP010509HU1 |
Size | Pls inquire |
Source | Yeast |
Have Questions? | Leave a Message or Start an on-line Chat |
Code | CSB-EP010509HU1-B |
Size | Pls inquire |
Source | E.coli |
Conjugate | Avi-tag Biotinylated E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag. |
Have Questions? | Leave a Message or Start an on-line Chat |
Code | CSB-BP010509HU1 |
Size | Pls inquire |
Source | Baculovirus |
Have Questions? | Leave a Message or Start an on-line Chat |
Code | CSB-MP010509HU1 |
Size | Pls inquire |
Source | Mammalian cell |
Have Questions? | Leave a Message or Start an on-line Chat |
The Recombinant Human HLA class I histocompatibility antigen, alpha chain G (HLA-G) is the extracellular domain protein from amino acid 25-308 of human HLA-G. Its purity is greater than 85% as measured by SDS-PAGE. This HLA-G protein is expressed in four expression systems, including Yeast, E.coli (in Vivo Biotinylation), Baculovirus, and mammalian cells. Prokaryotic and eukaryotic expressions give you more options for protein sources.
The target protein HLA-G is an immune tolerogenic molecule, which plays a crucial role in the inhibition of the immune responses by interacting with leukocyte receptors including LILRB1, LILRB2, and KIR2DL4. It facilitates the whole cancer immunoediting process by impairing anti-tumor immune responses. Abnormal expression of HLA-G is detected in many human solid malignant tumors in situ and malignant hematopoietic diseases such as acute myeloid leukemia and is associated with poor prognosis.
There are currently no reviews for this product.